41.6 Conclusion
Renal transplantation can be successfully performed in children with end-stage renal disease due to severe lower urinary tract dysfunction. Before transplantation, a stable urinary reservoir and storage system are necessary. Close surveillance is imperative in children who have undergone transplantation into an abnormal native bladder.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Churchill B.m., Jayanthi R.v., Mclorie G.a. Paediatric renal transplantation into the abnormal urinary tract. Pediatr Nephrol 1996; 10: 113.
Cruz F., Silva C. Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update. Curr Opin Urol 2004; 14: 329–334.
Fernandes E.t., Reinberg Y., Vernier R. Neurogenic bladder dysfunction in children: review of physiopathology and current management. J Pediatr 1994; 124: 1–7.
Fischbach M., Graff V., Terzic J. Impact of age on reference values for serum concentration of cystatin C in children. Pediatr Nephrol 2002; 17: 104–106.
Fontaine E., Gagnadoux M.f., Niaudet P. Renal transplantation in children with augmentation cystoplasty: long-term results. J Urol 1998; 159: 2110–2113.
Giannantoni A., Mearini E., Di Stasi S.m. New therapeutic options for refractory neurogenic detrusor overactivity. Minerva Urol Nefrol 2004; 56: 79–87.
Giannantoni A., Di Stasi S.m., Stephen R.L. Intravesical resiniratoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomised study. J Urol 2004; 172: 240–243.
Grunberg J., Rebori A., Verocay M.c. Peritoneal dialysis in children with spina bifida and ventriculoperitoneal shunt: one center’s experience and review of the literature. Perit Dial Int 2003; 23: 481–486.
Grundy D.j., Rainford D.j., Silver J.r. The occurrence of acute renal failure in patients with neuropathic bladder. Paraplegia 1982; 20: 35–42.
Hatch D.a., Koyle M.a., Baskin L.s. Kidney transplantation in children with urinary diversion or bladder augmentation. J Urol 2001; 165: 2265–2268.
Hellerstein S. letter to the editor: Neurogenic bladder dysfunction in children. J Pediatr 1994; 125: 333.
Jenkins M.a., Brown D.j., Lerino F.l. Cystatin C for estimation of glomerular filtration rate in patients with spinal cord injury. Ann Clin Biochem 2003; 40: 364–368.
Koo H.p., Bunchman T.e., Flynn J.t. Renal transplantation in children with severe lower urinary tract dysfunction. J Urol 1999; 161: 240–245.
Kuo H.c. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 2003; 170: 1908–1912.
Lawrenson R., Wyndaele J.j., Vlachonikolis I. A UK database study of prevalence and mortality of people with neural tube defects. Clin Rehabil 2000; 14: 627–630.
Lawrenson R., Wyndaele J.j., Vlachonikolis I. Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology 2001; 20: 138–143.
Leippold T., Reitz A., Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol 2003; 44: 165–174.
Macdiarmid S.a., Mcintyre W.j., Anthony A. Monitoring of renal function in patients with spinal cord injury. BJU Int 2000; 85: 1014–1018.
Melzer M., Ohry A., Hertz M. The status of the urinary tract in a survey of 92 cases with neurogenic bladder. Paraplegia 1976; 14: 213–219.
Mendizabal S., Estornell F., Zamora I. Renal transplantation in children with severe bladder dysfunction. J Urol 2005; 173: 226–229.
Mirahmadi M.k., Byrne C., Barton C. Prediction of creatinine clearance from serum creatinine in spinal cord injury patients. Paraplegia 1983; 21: 23–29.
Muller T., Arbeiter K., Aufricht C. Renal function in meningomyelocele: risk factors, chronic renal failure, renal replacement therapy and transplantation. Curr Opin Urol 2002; 12: 479–484.
Perkash I. Long-term urologic management of the patient with spinal cord injury. Urol Clin North Am 1993; 20: 423–434.
Quek M.l., Ginsberg D.a. Long-term urodynamics follow-up of bladder augmentation for neurogenic bladder. J Urol 2003; 169: 195–198.
Raj G.v., Bennett R.t., Preminger G.m. The incidence of nephrolithiasis in patients with spinal neural tube defects. J Urol 1999; 162: 1238–1242.
Reinberg Y., Fleming T., Gonzalez R. Renal rupture after the Credé maneuver. J Pediatr 1993; 124: 279–281.
Sedman A., Friedman A., Boineau. f. Nutritional management of the child with mild to moderate chronic renal failure. J Pediatr 1996; 129: 13–18.
Smith C.p., Nishiguchi J., Oleary M. Single institution experience in 110 patients with Botulinum toxin A injection into bladder or urethra. Urology 2005; 65: 37–41.
Sotolongo J.r. Urologic aspects of prevention of end-stage renal disease in spinal cord injury. Mount Sinai J Med 1993; 60: 299–301.
Thomassen S.a., Johannesen I.l., Erlandsen E.j. Serum cystatin C as a marker of the renal function in patients with spinal cord injury. Spinal Cord 2002; 40: 524–528.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Moog, R., Becmeur, F. (2006). Renal Failure and Neurogenic Bladder. In: Esposito, C., Guys, J.M., Gough, D., Savanelli, A. (eds) Pediatric Neurogenic Bladder Dysfunction. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-30867-9_41
Download citation
DOI: https://doi.org/10.1007/3-540-30867-9_41
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30866-9
Online ISBN: 978-3-540-30867-6
eBook Packages: MedicineMedicine (R0)